Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial. - Wikidata - wikimedia - TriplyDB

Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial.

Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial.

http://www.wikidata.org/entity/Q35065987

about

Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human Postrenal Transplant Human T-Cell Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis: A Case Report and Review of the Literature Molecular Studies of HTLV-1 Replication: An Update Roles of HTLV-1 basic Zip Factor (HBZ) in Viral Chronicity and Leukemic Transformation. Potential New Therapeutic Approaches to Prevent and Treat HTLV-1-Related Diseases Modes of Human T Cell Leukemia Virus Type 1 Transmission, Replication and Persistence Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis Treatment of HTLV-I-Associated Myelopathy / Tropical Spastic Paraparesis: Towards Rational Targeted Therapy Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases Susceptibility of primary HTLV-1 isolates from patients with HTLV-1-associated myelopathy to reverse transcriptase inhibitors.Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial Therapeutic benefits of an oral vitamin B1 derivative for human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis (HAM/TSP)Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy.Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.Interferon Beta-1a Improves Urinary Symptoms, Reduces Proviral Load, and Modifies the Immune Response in a Patient with HAM/TSP.Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease Long Terminal Repeat Circular DNA as Markers of Active Viral Replication of Human T Lymphotropic Virus-1 in Vivo.Treatment of adult T-cell leukemia/lymphoma: past, present, and future.Immune Compromise in HIV-1/HTLV-1 Coinfection With Paradoxical Resolution of CD4 Lymphocytosis During Antiretroviral Therapy: A Case Report.Timed walk as primary outcome measure of treatment response in clinical trials for HTLV-1-associated myelopathy: a feasibility study.CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.Neuroimmunity of HTLV-I Infection.Newer developments in adult T-cell leukemia/lymphoma therapeutics.Neuroimmunological aspects of human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis.Inflammatory manifestations of HTLV-1 and their therapeutic options.Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4.Molecular and clinical effects of betamethasone in human T-cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients.A plasma diagnostic model of human T-cell leukemia virus-1 associated myelopathy HTLV-1-associated myelopathy in a solid organ transplant recipient.Antiviral effect of raltegravir on HTLV-1 carriers.Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy.Human T-cell leukaemia virus type 1: parasitism and pathogenesis.Human T cell lymphotrophic virus 1/2 in solid organ transplantation.HTLV-1-associated myelopathy/tropical spastic paraparesis.HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment.How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy.[HTLV-1-associated myelopathy/tropical spastic paraparesis: a differential diagnosis in multiple sclerosis].HTLV-1, ATLL, severe hypercalcaemia and HIV-1 co-infection: an overview

P2860

Q21131133-CD9D13C8-7B53-4E54-B06A-3B5AE228C086 Q21245197-D3451E1A-7C07-4B28-90A5-28F393BA0CCF Q26700149-1077CE6A-39C7-4770-BE33-4EDE2C537A38 Q26772930-41D41712-80B0-4B3B-B50B-20924933C647 Q26774352-9B281599-011F-4C0B-AAEC-027B536782B2 Q26801294-30B492F6-C0B6-4184-A817-01E9005D5117 Q28484214-F1CE8892-7450-41A9-87AD-E45A1753D6C1 Q28972318-81F94FF2-7B43-4887-A4D3-4B0D64600A9D Q33983161-2AC13468-E4C1-4498-A1FD-2EC78F059587 Q34223814-2757EAEC-0779-43D0-A91D-35C9F6429891 Q34941384-73296F2C-A0F3-4FBB-8FA1-C181FC260E5C Q34941499-19BE5FB9-BF1D-4931-93E2-2E03D15D2AFD Q35989638-E087DA56-8F4C-4C5C-B8CD-46119B48DC5A Q36147455-31F40329-F18F-4386-BEC9-28B3F7C343ED Q36199924-F4FA9F11-8AAC-4E12-ABFC-F2AB4E98F8C3 Q36497719-FBE0AD2F-E513-47D1-87D0-9CF4F8AD50E9 Q36735681-A28D88EE-A617-4920-AFB3-847C9F0F9A54 Q37032793-A5183823-FE67-4BEA-9806-562F193EBCA2 Q37328362-ADD95699-97DB-4973-8E38-585B6D0C1C34 Q37498121-426FB613-B319-4303-B8A7-45D7E83DBBC1 Q37579811-2EAD63A6-99F0-424E-9FED-51FCF52AB75E Q37741036-FBDFFA92-34BA-4174-94DF-020C19BE5C78 Q37864326-4A1611C5-B300-4C9B-BF46-8663F5913A5B Q38128799-F5E1B5A2-63FA-44AF-B1E4-B74A002486A8 Q38262169-9CA0CD02-08C8-4BB8-B1D2-888C6CE1149B Q38538043-95C947C1-2763-4A29-94CD-93F2E9D91E7D Q38867574-ECD7DB97-4BAF-41B6-A4F3-48C704EC6840 Q39095729-75A62E03-9242-43DE-BE1B-D5CD9B02D303 Q39264203-239A0BF1-10E1-4A02-8593-2B6864265A2D Q39533380-2E9E58D2-E780-4888-96C7-B75C6E680692 Q39611634-8900E686-56D6-4AD2-AFCB-9F9B95B359AB Q40046615-FC0E08A5-7667-4AA3-A464-4F6E8D2617DC Q42272256-19EFC91B-09D1-4EBF-ABDE-A2C189832037 Q45096240-BE1218EE-7449-4296-9F8B-55B86BC928DE Q47562043-D7FDCB34-9D8B-4838-B132-5FEE01811243 Q54246489-96447751-6003-42D6-BBA3-246724240055 Q55239219-9960A5FF-BE94-4AA8-BD53-0CA0A3318F2A Q57825486-42F9A188-5AD9-40EE-B43E-49A94B926FBB

P2860

Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial.

http://www.wikidata.org/entity/Q35065987

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Zidovudine plus lamivudine in ...... yelopathy: a randomised trial.

@ast

Zidovudine plus lamivudine in ...... yelopathy: a randomised trial.

@en

type

label

Zidovudine plus lamivudine in ...... yelopathy: a randomised trial.

@ast

Zidovudine plus lamivudine in ...... yelopathy: a randomised trial.

@en

prefLabel

Zidovudine plus lamivudine in ...... yelopathy: a randomised trial.

@ast

Zidovudine plus lamivudine in ...... yelopathy: a randomised trial.

@en

P1433

Q35065987-D5BC48C5-B046-4BED-A6ED-4684B715E927

P1476

Q35065987-094EDDC2-9A69-4D9E-B3F0-23A7149E3E4B

P2093

Q35065987-19080F22-E3BE-429F-9F2B-28FCA32983EC

Q35065987-1E1388B8-D9C4-461C-8EFC-8E38AA74CEA3

Q35065987-27D2DD2A-E2EF-4404-B821-5EA2A5502916

Q35065987-5BDC0045-3574-4615-ABAC-2F78278CF098

Q35065987-702EF0EF-A16B-4DEB-9019-11DE3DA67842

Q35065987-740D2143-2056-41FF-86BD-7C06CBD57555

Q35065987-7C56389E-76FC-47D5-A2DE-1478EFA6C4DD

Q35065987-9BFA3E0C-DE5C-43D1-B9F5-323828E57A6E

Q35065987-AB259862-7618-4F5F-A001-49F4CD3D8269

Q35065987-ABB525DA-E086-47D9-897A-C1732DB2AE54

P2860

Q35065987-0454E396-A114-451E-B6BD-DD9BD5751F9A

Q35065987-07952FD5-EDEB-4826-BA28-540671145EF9

Q35065987-0F099A41-A3DC-4BCA-8175-7C30D94544B3

Q35065987-1534569B-40F1-4F0C-B515-1BDD57F19FCB

Q35065987-21436D85-3379-4141-87BA-85D0BE0A194A

Q35065987-3D83B52D-ED0C-4A40-AEEA-554B26FD4277

Q35065987-3E98532D-CB77-4D5A-9D1A-D655C1417300

Q35065987-46D7B8FE-D610-4C99-BA26-A3434836EBE0

Q35065987-483F1FBE-605F-43C2-9C1B-CFF75CBD8FA7

Q35065987-5B3AA868-0B44-4C8F-B3F8-E04A37766135

P2888

Q35065987-FC2C4F2C-2507-4AFD-BB3A-9A6D79565DCB

P304

Q35065987-85CA67FA-E333-4633-9D2A-A9DD1C839342

P31

Q35065987-4709013B-E4F8-4859-9ADB-E668BB9FCA65

P356

Q35065987-5C83C5B0-EE76-4639-9AF8-36439296D145

P478

Q35065987-E036A7E5-954E-4B1D-A20D-658621111BCF

P577

Q35065987-CC292343-9A00-4FE0-B565-636EF30064A1

P5875

Q35065987-5050BAAE-481D-4B1A-AC4E-98BD691DA99B

P6179

Q35065987-8A973F1C-10C6-4147-82CF-41F8F6F54EC2

P698

Q35065987-E0D747CF-8E96-4720-B1EC-B11602228F40

P921

Q35065987-CA16779E-5C70-40EF-A77A-F4F3EE2C929E

P932

Q35065987-50C48B81-6B49-4347-82D9-8EC7C8760940

P356

P1433

P1476

Zidovudine plus lamivudine in ...... yelopathy: a randomised trial.

@en

P2093

Abdel Babiker

http://www.w3.org/2001/XMLSchema#string

Angelina Mosley

http://www.w3.org/2001/XMLSchema#string

Anna Barfield

http://www.w3.org/2001/XMLSchema#string

Charles R M Bangham

http://www.w3.org/2001/XMLSchema#string

Graham P Taylor

http://www.w3.org/2001/XMLSchema#string

Hannah Green

http://www.w3.org/2001/XMLSchema#string

Hirohisa Nose

http://www.w3.org/2001/XMLSchema#string

Jonathan N Weber

http://www.w3.org/2001/XMLSchema#string

Koichiro Usuku

http://www.w3.org/2001/XMLSchema#string

Mitsuhiro Osame

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery of adult T-cell leukemia

The discovery of the first human retrovirus: HTLV-1 and HTLV-2

Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy

HTLV-I/II associated disease in England and Wales, 1993-7: retrospective review of serology requests.

Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors

The immune response to HTLV-I.

Effect of lamivudine on transmission of human T-cell lymphotropic virus type 1 to adult peripheral blood mononuclear cells in vitro

Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton.

Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I

Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients

P2888

P304

63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-4690-3-63

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6809109

http://www.w3.org/2001/XMLSchema#string

P6179

1050587886

http://www.w3.org/2001/XMLSchema#string

P698

16984654

http://www.w3.org/2001/XMLSchema#string

P921

Human T-lymphotropic virus 1

P932

1590049

http://www.w3.org/2001/XMLSchema#string